 |
|
Systemic review: agreement between the latent tuberculosis screening tests among patients with rheumatic diseases
Junhee Pyo, Soo-Kyung Cho, Dam Kim, Yoon-Kyoung Sung
Korean J Intern Med. 2018;33(6):1241-1251. Published online 2017 Dec 28 DOI: https://doi.org/10.3904/kjim.2016.222
|
|
Citations to this article as recorded by
 Prevalence of positive tuberculin skin test in a Brazilian sample of rheumatoid arthritis and spondylarthritis patients
Beatriz Silva Lemes, Carina Albuquerque Roberto, André Rochinski Busanello, Bárbara Stadler Kahlow, Thelma Skare, Renato Nisihara
Revista da Associação Médica Brasileira.2024;[Epub] CrossRef 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
George E Fragoulis, Elena Nikiphorou, Mrinalini Dey, Sizheng Steven Zhao, Delphine Sophie Courvoisier, Laurent Arnaud, Fabiola Atzeni, Georg MN Behrens, Johannes WJ Bijlsma, Peter Böhm, Costas A Constantinou, Silvia Garcia-Diaz, Meliha Crnkic Kapetanovic,
Annals of the Rheumatic Diseases.2023; 82(6): 742. CrossRef Latent Tuberculosis Infection and Associated Factors in Patients with Systemic Lupus Erythematosus: a Multicenter, Cross-Sectional Study
Lifan Zhang, Yanan Ma, Nan Jiang, Xiaoqing Zou, Yueqiu Zhang, Fengchun Zhang, Xiaofeng Zeng, Yan Zhao, Shengyun Liu, Xiaoxia Zuo, Huaxiang Wu, Lijun Wu, Hongbin Li, Zhiyi Zhang, Sheng Chen, Ping Zhu, Miaojia Zhang, Wencheng Qi, Yi Liu, Huaxiang Liu, Xiaoc
Microbiology Spectrum.2023;[Epub] CrossRef Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
George E Fragoulis, Mrinalini Dey, Sizheng Zhao, Jan Schoones, Delphine Courvoisier, James Galloway, Kimme L Hyrich, Elena Nikiphorou
RMD Open.2022; 8(2): e002726. CrossRef The clinical utility of tuberculin skin tests: a single-center experience
Omer Yesil, Yasin Gokmen, Fatih Üzer, Sukriye Oner, Tülay Ozdemir
Colombia Medica.2022;[Epub] CrossRef Risk of Tuberculosis Development in Patients with Rheumatoid Arthritis Receiving Targeted Therapy: a Prospective Single Center Cohort Study
Yeo-Jin Song, Soo-Kyung Cho, Hyoungyoung Kim, Hye Won Kim, Eunwoo Nam, Sang-Cheol Bae, Dae Hyun Yoo, Yoon-Kyoung Sung
Journal of Korean Medical Science.2021;[Epub] CrossRef Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018
Tessa du Toit, Tonya M. Esterhuizen, Nicki Tiffin, Ahmed A. Abulfathi, Helmuth Reuter, Eric H. Decloedt
BMC Infectious Diseases.2020;[Epub] CrossRef Screening for latent tuberculosis infection prior to biologic therapy in patients with chronic immune-mediated inflammatory diseases (IMID): Interferon-gamma release assay (IGRA) versus tuberculin skin test (TST)
Meriem Sellami, Alia Fazaa, Myriam Cheikh, Saousen Miladi, Kmar Ouenniche, Rym Ennaifer, Kaouther Ben Abdelghani, Ahmed Laatar
The Egyptian Rheumatologist.2019; 41(3): 225. CrossRef Latent tuberculosis infection and non-infectious co-morbidities: Diabetes mellitus type 2, chronic kidney disease and rheumatoid arthritis
Cesar Ugarte-Gil, Rodrigo M. Carrillo-Larco, Daniela E. Kirwan
International Journal of Infectious Diseases.2019; 80: S29. CrossRef
|